NMDA inhibitors (Syntrix Biosystems)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNMDA inhibitors (Syntrix Biosystems)
Drug Alias NameNMDA inhibitors (Syntrix Biosystems/University of Medicine and Dentistry of New Jersey)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsNeurotoxicity Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Medicine And Dentistry Of New Jersey
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSyntrix Biosystems Inc
Active IndicationsN/A
Inactive IndicationsNeurotoxicity Syndromes

Other Information

ATC CodeN/A
Related LinksN/A